Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Covalent Group Inc (CVGR) an undiscovered CRO -- Ignore unavailable to you. Want to Upgrade?

To: T A P who wrote (95)	3/13/2000 12:28:00 PM
From: JanyBlueEyes	Read Replies (1) \| Respond to of 107

News - West Coast Office Covalent Group, Inc. Announces Opening of West Coast Office WAYNE, Pa., March 13 /PRNewswire/ -- Covalent Group, Inc. (Nasdaq: CVGR) announced today the opening of a new office in San Diego, California. Kenneth M. Borow, M.D., Chief Executive Officer of Covalent said, "The addition of an office in San Diego follows the opening of our European headquarters in London several months ago, and is an important part of our geographic expansion plan. As we continue to broaden our strategic reach, we are in a better position to service our west coast biotech and pharmaceutical client base and bring to bear the broad experience of Covalent's key staff, especially in the areas of clinical and consultative services, project management, regulatory affairs, data management and financial services." Covalent Group, Inc. provides drug development services and health management solutions to pharmaceutical, biotechnology, and device manufacturers as well as managed care organizations. To aid its customers, Covalent has developed several currently available proprietary products utilizing interactive speech recognition technology including TeleTrial(R), for use in clinical trials, and Virtual HouseCall(R), a disease assessment system. This document contains statements of a forward-looking nature.